SciVision Biotech Inc.

Taiwan Stock Exchange 1786.TW

SciVision Biotech Inc. Dividend Yield on January 14, 2025: 1.78%

SciVision Biotech Inc. Dividend Yield is 1.78% on January 14, 2025, a -30.41% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

SciVision Biotech Inc. 52-week high Dividend Yield is 2.65% on January 17, 2024, which is 48.46% above the current Dividend Yield.
SciVision Biotech Inc. 52-week low Dividend Yield is 1.45% on August 20, 2024, which is -18.73% below the current Dividend Yield.
SciVision Biotech Inc. average Dividend Yield for the last 52 weeks is 1.92%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Taiwan Stock Exchange: 1786.TW

SciVision Biotech Inc.

CEO	Tai Xian Han
IPO Date	March 12, 2013
Location	Taiwan
Headquarters	1, South 1st Road
Employees	64
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials Cosmetics

Description

SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. It offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. The company was founded in 2001 and is based in Kaohsiung, Taiwan.

Key trends

Past 5 years